NCT05525000 (ValOpti) is a NA clinical trial of Validation in Health Care Utilization, sponsored by Ludwig Boltzmann Institute for Digital Health and Prevention.

Who is sponsoring NCT05525000?

NCT05525000 is sponsored by Ludwig Boltzmann Institute for Digital Health and Prevention.

What drugs are being tested in NCT05525000?

Interventions in NCT05525000: Validation.

What condition does NCT05525000 study?

NCT05525000 studies Health Care Utilization.

Is NCT05525000 still recruiting?

NCT05525000 is currently completed. Last updated 16 October 2023.

Last reviewed 2023-10-16 · How we verify

NCT05525000: ValOpti

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Validity and Reliability of Optical Heart Rate Sensors

Completed NA Last updated 16 October 2023

What this trial tests

NA trial testing Validation in Health Care Utilization in 32 participants. Completed in 18 January 2023.

Timeline

25 May 2022

Primary endpoint
1 January 2023

18 January 2023

Quick facts

Lead sponsor	Ludwig Boltzmann Institute for Digital Health and Prevention
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	32
Start date	25 May 2022
Primary completion	1 January 2023
Estimated completion	18 January 2023
Sites	1 location across Austria

Drugs / interventions tested

Validation

Conditions studied

Health Care Utilization — all drugs for Health Care Utilization →

Sponsor

Ludwig Boltzmann Institute for Digital Health and Prevention

Who can join

35 and older, any sex, with Health Care Utilization. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate validity and reliability of consumer-grade optical heart-rate devices we aim to compare these devices with medical-grade ECG. The design includes an extended and practical validation protocol for consumer-grade optical heart rate devices in laboratory and ambulatory free-living conditions using a medical-grade ECG device as a criterion measure.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Validity of Four Consumer-Grade Optical Heart Rate Sensors for Assessing Volume and Intensity Distribution of Physical Activity.
Neudorfer M, Kumar D, Smeddinck JD, Kulnik ST, et al · · 2024 · cited 6× · PMID 39508366 · DOI 10.1111/sms.14756
Validation of the Polar Fitness Test for Estimation of Maximal Oxygen Consumption at Rest in Medically Supervised Exercise Training: Comparison with CPET and the 6-Minute Walk Test.
Neudorfer M, Ötzlinger L, Kumar D, Niebauer J, et al · · 2025 · PMID 41012888 · DOI 10.3390/s25185649

Verify or expand the search:

Other trials of Validation

Trials testing the same drug.

NCT04563858 — Polish Validation 4AT Tool · completed

Other recruiting trials for Health Care Utilization

Currently open trials in the same condition.

NCT06999928 — Enhanced Mentor Mother Strategy for Pregnant and Postpartum Women Living With HIV · NA · recruiting
NCT06604559 — The Effect of Patient Discharge From the Maternal and Fetal Medicine Unit With Receiving a Discharge Letter Later Using · NA · recruiting
NCT05454969 — One-4-ALL Initiative · NA · recruiting
NCT05989282 — Structural Conditions and Health After Release From Prison · recruiting
NCT06186128 — Universal Basic Income and Structural Racism in the US South: HIV Care · NA · recruiting

Other Ludwig Boltzmann Institute for Digital Health and Prevention trials

Trials by the same sponsor.

NCT06321926 — Evaluation of the "ActiveWaiting App" Encouraging Active Exercise-related Use of Waiting Time · NA · completed
NCT06025526 — Effectiveness of the Aktivplan Digital Intervention (ACTIVE-CaRe Pilot) · NA · completed
NCT04501432 — Cardiac Rehabilitation and Ongoing Physical Activity During COVID-19 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05525000 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ludwig Boltzmann Institute for Digital Health and Prevention
Last refreshed: 16 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05525000.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing